BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 22202053)

  • 1. The potential origin of glioblastoma initiating cells.
    Chesler DA; Berger MS; Quinones-Hinojosa A
    Front Biosci (Schol Ed); 2012 Jan; 4(1):190-205. PubMed ID: 22202053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SVZ and Its Relationship to Stem Cell Based Neuro-oncogenesis.
    Kusne Y; Sanai N
    Adv Exp Med Biol; 2015; 853():23-32. PubMed ID: 25895705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of cancer-initiating cells within glioblastoma.
    Binda E; Visioli A; Reynolds B; Vescovi AL
    Front Biosci (Schol Ed); 2012 Jun; 4(4):1235-48. PubMed ID: 22652868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pten and p53 converge on c-Myc to control differentiation, self-renewal, and transformation of normal and neoplastic stem cells in glioblastoma.
    Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; dePinho RA
    Cold Spring Harb Symp Quant Biol; 2008; 73():427-37. PubMed ID: 19150964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer Stem Cells: Significance in Origin, Pathogenesis and Treatment of Glioblastoma.
    Biserova K; Jakovlevs A; Uljanovs R; Strumfa I
    Cells; 2021 Mar; 10(3):. PubMed ID: 33799798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells.
    Golebiewska A; Bougnaud S; Stieber D; Brons NH; Vallar L; Hertel F; Klink B; Schröck E; Bjerkvig R; Niclou SP
    Brain; 2013 May; 136(Pt 5):1462-75. PubMed ID: 23460667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glioblastoma stem cells.
    Tabatabai G; Weller M
    Cell Tissue Res; 2011 Mar; 343(3):459-65. PubMed ID: 21253762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous transformation of human adult nontumorigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastoma.
    Shiras A; Chettiar ST; Shepal V; Rajendran G; Prasad GR; Shastry P
    Stem Cells; 2007 Jun; 25(6):1478-89. PubMed ID: 17332509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glioblastoma cancer stem-like cells: implications for pathogenesis and treatment.
    Nduom EK; Hadjipanayis CG; Van Meir EG
    Cancer J; 2012; 18(1):100-6. PubMed ID: 22290263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma.
    Galli R; Binda E; Orfanelli U; Cipelletti B; Gritti A; De Vitis S; Fiocco R; Foroni C; Dimeco F; Vescovi A
    Cancer Res; 2004 Oct; 64(19):7011-21. PubMed ID: 15466194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A molecular screening approach to identify and characterize inhibitors of glioblastoma stem cells.
    Visnyei K; Onodera H; Damoiseaux R; Saigusa K; Petrosyan S; De Vries D; Ferrari D; Saxe J; Panosyan EH; Masterman-Smith M; Mottahedeh J; Bradley KA; Huang J; Sabatti C; Nakano I; Kornblum HI
    Mol Cancer Ther; 2011 Oct; 10(10):1818-28. PubMed ID: 21859839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse models to interrogate the implications of the differentiation status in the ontogeny of gliomas.
    Muñoz DM; Guha A
    Oncotarget; 2011 Aug; 2(8):590-8. PubMed ID: 21896959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal differentiation of glioblastoma stem cells.
    Ricci-Vitiani L; Pallini R; Larocca LM; Lombardi DG; Signore M; Pierconti F; Petrucci G; Montano N; Maira G; De Maria R
    Cell Death Differ; 2008 Sep; 15(9):1491-8. PubMed ID: 18497759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem cells in glioblastoma.
    Lathia JD; Mack SC; Mulkearns-Hubert EE; Valentim CL; Rich JN
    Genes Dev; 2015 Jun; 29(12):1203-17. PubMed ID: 26109046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain tumour stem cells: possibilities of new therapeutic strategies.
    Piccirillo SG; Vescovi AL
    Expert Opin Biol Ther; 2007 Aug; 7(8):1129-35. PubMed ID: 17696813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glioblastoma and stem cells.
    Altaner C
    Neoplasma; 2008; 55(5):369-74. PubMed ID: 18665745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus infection promotes the formation of glioma stem cells from glioblastoma cells through the TLR9/NEAT1/STAT3 pathway.
    Zang J; Zheng MH; Cao XL; Zhang YZ; Zhang YF; Gao XY; Cao Y; Shi M; Han H; Liang L
    Cell Commun Signal; 2020 Aug; 18(1):135. PubMed ID: 32843056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse induced glioma-initiating cell models and therapeutic targets.
    Kondo T
    Anticancer Agents Med Chem; 2010 Jul; 10(6):471-80. PubMed ID: 20879984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The status of the art of human malignant glioma management: the promising role of targeting tumor-initiating cells.
    Florio T; Barbieri F
    Drug Discov Today; 2012 Oct; 17(19-20):1103-10. PubMed ID: 22704957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
    Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
    Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.